PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 29521111-9 2018 RESULTS: Good agreement was observed between C-peptide concentrations in plasma and equivalent DBS and VAMS samples ( R2 = .929 and .9231, DBS and VAMS, respectively), with mean differences of 75.7 and 8.4 pmol/L observed for DBS and VAMS. dbs 139-142 insulin Homo sapiens 45-54 29521111-9 2018 RESULTS: Good agreement was observed between C-peptide concentrations in plasma and equivalent DBS and VAMS samples ( R2 = .929 and .9231, DBS and VAMS, respectively), with mean differences of 75.7 and 8.4 pmol/L observed for DBS and VAMS. dbs 139-142 insulin Homo sapiens 45-54 29860430-10 2018 The correlation of the C-peptide slope over time (assessed by repeated home DBS) vs area under the curve during the two MMTTs was r = 0.73 (P < 0.001). dbs 76-79 insulin Homo sapiens 23-32 29860430-11 2018 Mixed models showed that a 1-month increase in diabetes duration was associated with 17-pmol/L decline in fasting DBS C-peptide, whereas increases of 1 mmol/L in glucose, 1 year older age at diagnosis, and 100 pmol/L higher baseline plasma C-peptide were associated with 18, 17, and 61 pmol/L higher fasting DBS C-peptide levels, respectively. dbs 114-117 insulin Homo sapiens 118-127 29521111-10 2018 Small decreases in C-peptide of 11.6% and 0.1% were observed after 48 hours storage for DBS and VAMS, respectively. dbs 88-91 insulin Homo sapiens 19-28 29521111-11 2018 CONCLUSIONS: C-peptide collected using DBS and VAMS showed good agreement with reference plasma concentrations, suggesting both would be an effective microsampling method for collection and measurement of C-peptide. dbs 39-42 insulin Homo sapiens 13-22 26565377-3 2016 AIM: The aim of this study is to determine the effect of haematocrit on insulin concentrations from DBS. dbs 100-103 insulin Homo sapiens 72-79 26565377-5 2016 DBS were analysed for insulin using the method developed by Butter et al. dbs 0-3 insulin Homo sapiens 22-29 26565377-11 2016 Plasma insulin concentrations from neonatal DBS were typically higher than paired plasma samples. dbs 44-47 insulin Homo sapiens 7-14 26565377-12 2016 CONCLUSIONS: Haematocrit has a significant effect on insulin measurement by chemiluminescence when using DBS. dbs 105-108 insulin Homo sapiens 53-60 26565377-14 2016 DBS insulin concentrations higher than plasma indicate that insulin may be present in red blood cells. dbs 0-3 insulin Homo sapiens 4-11 26565377-14 2016 DBS insulin concentrations higher than plasma indicate that insulin may be present in red blood cells. dbs 0-3 insulin Homo sapiens 60-67 26565377-15 2016 However, measuring plasma insulin concentrations with DBS in neonates is not ideal due to high variability. dbs 54-57 insulin Homo sapiens 26-33